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Th e fi rst epileptic seizure needs to be evaluated by 
a neurologist. Th e comprehensive assessment includes 
detailed clinical history, EEG, neuroimaging, bio-
chemical blood tests, including glucose, urin toxicol-
ogy and sometimes CSF testing.
In the patients with their fi rst seizures hospitaliza-
tion may be required to confi rm diagnosis. However, 
if the seizure is longer and the patient has still de-
creased level of consciousness, or has a series of epi-
leptic seizures, focal neurological defi cit, febrile state 
or positive meningeal signs, these may also require 
stay in hospital. 
In majority of patients, the fi rst seizure is usually 
not indication for starting with antiepileptic drug 
(AED). Furthermore, if the patient has a brief clus-
ters of epileptic seizures in a short period of time that 
spontaneously stop, we may treat this as a single sei-
zure. 
However, there are some exceptions to these rules, 
when we put patients on an AED - this depends on 
type of epilepsy (absance or IGE), clinical semiology 
and clinical history (head trauma or CNS infection), 
in particular when the seizures are longer and the pa-
tient does not regain consciousness between two sei-
zures. AED is also started in situations when we have 
a patient with two longer seizure clusters in 24 hours 
or in symptomatic seizures, as part of other, systemic 
disease (expansive cerebral lesion). In general, these 
exceptions are rare.
It is recommended that the fi rst seizure is treated 
with lorazepam or diazepam. When we decide to start 
treatment with AED, the prescribed AED needs to 
be tailored for individual needs. Current evidence 
shows that in 20-25% patients the fi rst AED will not 
stop seizures. In 10-17% the patient will experience 
AED side-eff ects and in 5-6% idiosynchratic reac-
tions. About 8% of additional patients will not tol-
erate AED due to other reasons (Kwan and Brodie, 
2001). One of larger retrospective studies examined 
eff ect of carbamazepine, valproate and lamotrigine to 
determine optimal AED daily dose. In the patients 
with complete seizure control, the average daily dose 
of carbamazepine was 600mg (400-600mg), valproate 
1000mg (800-1000mg) or lamotrigine 180mg (150-
200mg) (Mohanraj and Brodie, 2005). If the fi rst 
AED was not satisfactopry, then we replace it with 
another fi rst-line AED. Th e fi rst AED is later stopped 
and this is a monotherapy principle. Th e second-line 
AED is prescribed only as an add-on AED, because 
it failed to show better outcome in prior randomized 
stuides. More than two AED very rarely improve sei-
zure control, and three AEDs never. Diffi  cult to treat 
epilepsies is better to control with 1-2 AEDs than 
with three or more, due to signifi cant AEDs’ side-ef-
fects. More often used combinations of two AEDs are 
lamotrigine with valproate or levetiracetam, carbam-
azepine with topiramate or levetiracetam, or valproate 
with gabapentin.
